Tiaramide hydrochloride
CAS No. 35941-71-0
Tiaramide hydrochloride( tiaramide | FK-1160 | FK 1160 | FK1160 | NTA-194 )
Catalog No. M24316 CAS No. 35941-71-0
Tiaramide hydrochloride is an anti-inflammatory drug that inhibits the action of mediators released from mast cells and has direct smooth muscle relaxant properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 140 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 315 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | 910 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTiaramide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionTiaramide hydrochloride is an anti-inflammatory drug that inhibits the action of mediators released from mast cells and has direct smooth muscle relaxant properties.
-
DescriptionTiaramide hydrochloride is an anti-inflammatory drug that inhibits the action of mediators released from mast cells and has direct smooth muscle relaxant properties.
-
In Vitro——
-
In Vivo——
-
Synonymstiaramide | FK-1160 | FK 1160 | FK1160 | NTA-194
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35941-71-0
-
Formula Weight392.3
-
Molecular FormulaC15H19Cl2N3O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCN(CC1)CCN1C(CN(c(cc(cc1)Cl)c1S1)C1=O)=O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takano S. Inhibition of phospholipase A2 by tiaramide in rabbit platelets. Jpn J Pharmacol. 1985 Nov;39(3):307-16. PubMed PMID: 3005729.
molnova catalog
related products
-
Ac-IEVDIDVE (TFA)
Ac-IEVDIDVE TFA is a short peptide sequence.
-
Telocinobufagin
Telocinobufagin is the major endogenous digitalis-like factor.
-
ML-180
ML-180 is a potent orphan nuclear receptor liver receptor homolog 1 (LRH-1; NR5A2) inverse agonist (IC50 of 3.7 μM) .ML-180 (0.5-5 μM; 24 hours) shows a significant inhibition of cyclin-D1 and cyclin-E1 expression in hepatic cells, but has little effect on repression in SK-OV-3 cells[2]. ML-180 (5 μM; 24 hours) leads to a rapid decrease of LRH-1 expression and efficiently represses endogenous LRH-1 signaling.
Cart
sales@molnova.com